Meeting
2024 ASCO Annual Meeting
Association of machine learning (ML)–derived histological features with transcriptomic molecular subtypes in advanced renal cell carcinoma (RCC).
Authors
Niha Beig
Genentech, South San Francisco, CA
Niha Beig , Shima Nofallah , David F. McDermott , Robert J. Motzer , Thomas Powles , Brian I. Rini , Hartmut Koeppen , Romain Banchereau , Miles Markey , Isaac Finberg , Geetika Singh , Limin Yu , Robert Egger , Chintan Parmar , Jake Conway , Stephanie Hennek , Daniel Ruderman , Samuel Vilchez , Mahrukh A Huseni , Jennifer Margaret Giltnane
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Biologic Correlates
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 4519)
DOI
10.1200/JCO.2024.42.16_suppl.4519
Abstract #
4519
Poster Bd #
214
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Network meta-analysis (NMA) to assess comparative efficacy of lenvatinib plus pembrolizumab compared with other first-line treatments for management of advanced renal cell carcinoma (aRCC).
First Author: Viktor Grünwald
Poster
2022 ASCO Genitourinary Cancers Symposium
A VA Federal Supply Schedule (VAFSS)–based cost-effectiveness analysis of immunotherapy-tyrosine kinase inhibitor (IO-TKI) regimens and sunitinib in the treatment of metastatic renal cell carcinoma (mRCC).
First Author: Manish Kohli
Poster
2020 Genitourinary Cancers Symposium
Molecular characteristics of renal cell carcinoma (RCC) risk groups from JAVELIN Renal 101.
First Author: Toni K. Choueiri
Poster
2020 Genitourinary Cancers Symposium
Relative risk of pneumonitis associated with first-line use of immune checkpoint inhibitors in advanced renal cell carcinoma.
First Author: Nusrat Jahan